CAMX:STO
Camurus AB
SEK ७२५.५०
arrow_downward
-१.९६%(-१४.५०) 1D
नोभेम्बर १७, १५:४७:२८ GMT+१ · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CAMX...
Open
SEK ७३६.००
High
SEK ७३९.००
Low
SEK ७२४.५०
Mkt. cap
४४.८१ अरब
Avg. vol.
१.०७ लाख
Volume
५०.१४ हजार
52-wk high
SEK ७५०.००
52-wk low
SEK ४३०.८०
Shares outstanding
६.०६ करोड
No. of employees
३२३
Open
SEK ७३६.००
High
SEK ७३९.००
Low
SEK ७२४.५०
Mkt. cap
४४.८१ अरब
Avg. vol.
१.०७ लाख
Volume
५०.१४ हजार
52-wk high
SEK ७५०.००
52-wk low
SEK ४३०.८०
Shares outstanding
६.०६ करोड
No. of employees
३२३
News stories
From web sources and news partners
ChartMill
·
१ घण्टा पहिले
S&P 500 Premarket Movers on Nov. 17: Gainers and Losers
The Motley Fool
·
३१ मिनेट पहिले
Prediction: Dec. 9 Will Mark a Turning Point for the S&P 500
FOREX.com
·
१ घण्टा पहिले
S&P 500 forecast: Why US stocks have largely defied gravity and what could trigger a correction
Traders Union
·
४७ मिनेट पहिले
S&P 500 could deliver 18% total return by 2027, Goldman Sachs projects
Profile
Camurus AB is a Swedish research-based pharmaceutical and biotechnology company specialising in the commercialization of medicines for treating serious and chronic diseases. Established in 1991 and based in the southern university city of Lund, in the Medicon Valley region, the company is listed on Nasdaq Stockholm, Mid Cap.
Camurus was founded by scientists in biophysical, food, and pharmaceutical chemistry with expertise in lipid phase structures. The company provides nanoscale drug-delivery systems for development of high-value therapeutics. Wikipedia
About Camurus AB